apomorphine has been researched along with d-alpha tocopherol in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Levivier, M; Przedborski, S | 1 |
Behrens, S; Emrich, A; Gattaz, WF | 1 |
Behzadi, G; Roghani, M | 1 |
Andreazza, AC; Salvador, M; Soares, DG | 1 |
Abdulla, A; Kaklotar, D; Muthu, MS; Pandey, BL; Rajesh, CV; Sahu, AK; Singh, S | 1 |
da Silva Neto, MR; de Gomes, MG; de Oliveira Pacheco, C; Dos Santos, RB; Giacomeli, R; Haas, SE; Maciel, TR; Parisotto, AJM; Ribeiro, ACF | 1 |
2 review(s) available for apomorphine and d-alpha tocopherol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Current therapeutic approach in Parkinson disease].
Topics: Antiparkinson Agents; Apomorphine; Bromocriptine; Fetal Tissue Transplantation; Humans; Levodopa; Mesencephalon; Parkinson Disease; Selegiline; Vitamin E | 1992 |
6 other study(ies) available for apomorphine and d-alpha tocopherol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia.
Topics: Animals; Apomorphine; Behavior, Animal; Dopamine; Dyskinesia, Drug-Induced; Grooming; Haloperidol; Male; Rats; Rats, Wistar; Stereotyped Behavior; Vitamin E | 1993 |
Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence.
Topics: Amphetamine; Animals; Apomorphine; Atrophy; Axonal Transport; Corpus Striatum; Disease Models, Animal; Male; Motor Activity; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Vitamin E; Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 2001 |
Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems.
Topics: Antioxidants; Apomorphine; Ascorbic Acid; Benzothiazoles; beta Carotene; Biphenyl Compounds; Butylated Hydroxytoluene; Hydrogen Peroxide; Hydroxyl Radical; Oxidation-Reduction; Paraquat; Picrates; Propyl Gallate; Resveratrol; Saccharomyces cerevisiae; Stilbenes; Sulfonic Acids; Vitamin E | 2003 |
Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Chemistry, Pharmaceutical; Drug Compounding; Drug Delivery Systems; Mice; Micelles; Paliperidone Palmitate; Particle Size; Polyethylene Glycols; Psychotic Disorders; Vitamin E | 2016 |
Surface-functionalized curcumin-loaded polymeric nanocapsules could block apomorphine-induced behavioral changes in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Curcumin; Dopamine Agonists; Enzyme Inhibitors; Hexoses; Nanocapsules; Plants, Medicinal; Rats; Stereotyped Behavior; Treatment Outcome; Vitamin E | 2022 |